argenx Reports Topline Results from ADDRESS Study of Efgartigimod SC in Pemphigus

Go back to argenx Reports Topline Results from ADDRESS Study of Efgartigimod SC in Pemphigus
(NASDAQ: ARGX) Delayed: 990.32 --0 (-0%)
Previous Close $990.32    52 Week High
Open $990.32    52 Week Low
Day High $990.32    P/E N/A 
Day Low $990.32    EPS
Volume 15       

(NASDAQ: ARGX) Delayed: 990.32 --0 (-0%)
Previous Close $990.32    52 Week High
Open $990.32    52 Week Low
Day High $990.32    P/E N/A 
Day Low $990.32    EPS
Volume 15